Terns Pharmaceuticals (TERN) Total Debt (2020)
Terns Pharmaceuticals (TERN) has disclosed Total Debt for 1 consecutive years, with $12.9 million as the latest value for Q4 2020.
- For the quarter ending Q4 2020, Total Debt changed N/A year-over-year to $12.9 million, compared with a TTM value of $12.9 million through Dec 2020, changed N/A, and an annual FY2020 reading of $12.9 million, changed N/A over the prior year.
- Total Debt was $12.9 million for Q4 2020 at Terns Pharmaceuticals.
- Across five years, Total Debt topped out at $12.9 million in Q4 2020 and bottomed at $12.9 million in Q4 2020.